Table 5

Dissaggregated incremental effectiveness in 50-yr-old males treated with nasal continuous positive airway pressure (nCPAP) for two time horizons

Car accidentsCardiovascular riskUtility effect
TreatedUntreatedTreatedUntreatedTreatedUntreated
RR car accidents18.11111
RR CHD1111.18511
RR stroke1111.35311
Utility11110.7380.811
5-yr time horizon
Effectiveness4.5964.5954.5964.5933.7283.392
Incremental effectiveness#0.001 (0.3)0.003 (0.9)0.336 (98.8)
Lifespan time horizon
Effectiveness17.72917.69117.72917.51314.37813.084
Incremental effectiveness#0.038 (2.4)0.216 (14.0)1.294 (83.6)
  • Incremental effectiveness data are presented as disaggregated incremental effectiveness (percentage of total incremental effectiveness)

  • RR: relative risk

  • CHD: coronary heart disease

  • #: difference between the effectiveness estimated with and without treatment for each scenario analysed